• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

University of Michigan - Articles and news items

These tiny structures inside the kidney, called glomerular filters, suffer damage from diabetes and grow less effective at filtering the blood. The basic research that led to the clinical trial found that a cell-signaling pathway inside these structures could be a drug target -- and an existing drug being developed for arthritis already targeted that pathway. CREDIT: University of Michigan

Arthritis drug baricitinib re-aimed to target diabetic kidney disease

Industry news / 10 June 2015 / Victoria White

Researchers have presented promising results from a clinical trial of the experimental drug baricitinib in people with diabetic kidney disease…


Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +